跳至主要内容
临床试验/NCT00982605
NCT00982605Unknown不适用

EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes

Heidelberg University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2009年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1

研究概览

简要总结

The purpose of this study is to perform molecular diagnostic in mediastinal lymph nodes of non-small cell lung cancer patients sampled by endobronchial ultrasound guided finde needle aspiration (EBUS-TBNA).

详细描述

NSCLC is a common cancer. Accurate and early staging has a significant impact on outcome. EBUS-TBNA of involved mediastinal lymph nodes is critical. Molecular markers could improve mediastinal staging.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Samples are collected before surgery or before any therapy
  • ECOG 0 or 1
  • Clinical stage I-II, T1-2, N0-1, M0)
  • Surgically respectable
  • Patient with enlarged med. lymphnodes (control group)

排除标准

  • Previous RT/CHT
  • Previous or current cancer of other entity

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验